HomeCompareLHDX vs EQR

LHDX vs EQR: Dividend Comparison 2026

LHDX yields 442.18% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LHDX wins by $24061.26M in total portfolio value
10 years
LHDX
LHDX
● Live price
442.18%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24061.31M
Annual income
$16,652,908,317.91
Full LHDX calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — LHDX vs EQR

📍 LHDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLHDXEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LHDX + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LHDX pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LHDX
Annual income on $10K today (after 15% tax)
$37,585.67/yr
After 10yr DRIP, annual income (after tax)
$14,154,972,070.22/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, LHDX beats the other by $14,154,967,415.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LHDX + EQR for your $10,000?

LHDX: 50%EQR: 50%
100% EQR50/50100% LHDX
Portfolio after 10yr
$12030.68M
Annual income
$8,326,456,896.75/yr
Blended yield
69.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LHDX
Analyst Ratings
1
Hold
1
Sell
Consensus: Hold
Altman Z
-3.0
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LHDX buys
0
EQR buys
0
No recent congressional trades found for LHDX or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLHDXEQR
Forward yield442.18%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$24061.31M$47.8K
Annual income after 10y$16,652,908,317.91$5,475.61
Total dividends collected$23397.53M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: LHDX vs EQR ($10,000, DRIP)

YearLHDX PortfolioLHDX Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$54,918$44,218.44$11,380$679.82+$43.5KLHDX
2$285,717$226,953.99$13,014$837.25+$272.7KLHDX
3$1,409,215$1,103,497.88$14,961$1,036.20+$1.39MLHDX
4$6,594,479$5,086,619.59$17,297$1,289.22+$6.58MLHDX
5$29,301,933$22,245,840.16$20,121$1,613.15+$29.28MLHDX
6$123,733,671$92,380,602.86$23,561$2,030.84+$123.71MLHDX
7$496,971,503$364,576,474.39$27,783$2,573.54+$496.94MLHDX
8$1,900,271,005$1,368,511,496.83$33,013$3,284.39+$1900.24MLHDX
9$6,923,738,907$4,890,448,931.51$39,547$4,223.51+$6923.70MLHDX
10$24,061,308,948$16,652,908,317.91$47,791$5,475.61+$24061.26MLHDX

LHDX vs EQR: Complete Analysis 2026

LHDXStock

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Full LHDX Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this LHDX vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LHDX vs SCHDLHDX vs JEPILHDX vs OLHDX vs KOLHDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.